Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer
Cancer Treatment Reviews2016Vol. 48, pp. 50–60
Citations Over TimeTop 10% of 2016 papers
Nicholas G. Zaorsky, Talha Shaikh, Colin T. Murphy, M.A. Hallman, S.B. Hayes, Mark L. Sobczak, Eric M. Horwitz
Related Papers
- → Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy(2017)11 cited
- → High–intermediate prostate cancer treated with low-dose-rate brachytherapy with or without androgen deprivation therapy(2017)8 cited
- → Long-term outcome of high-risk prostate cancer treated with brachytherapy combined with external-beam radiation therapy and androgen deprivation therapy.(2014)1 cited
- → Androgen Deprivation Therapy in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy: A Multi-institutional Propensity Score Matched Pair Analysis(2014)
- → Reply to comment on: Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial(2022)